文献速递青光眼角膜与眼表疾病

原发性闭角型青光眼术后眼表变化与滤过泡形态的相关性

[Correlation of ocular surface changes with filtering bleb morphology after antiglaucoma surgery for primary angle-closure glaucoma].
PubMed 文献 · Zhonghua Yan Ke Za Zhi · 2026-01-01

回顾性纳入51例接受超声乳化联合小梁切除术的原发性闭角型青光眼患者,术后6个月最佳矫正视力改善、眼压显著下降,完全成功率96.1%。术后3个月非接触式泪膜首次破裂时间和眼表疾病指数问卷一过性下降、6个月恢复,睑板腺功能评分随时间升高。角膜染色评分与滤过泡血管化及5-氟尿嘧啶注射次数呈正相关。

要点

  • 术后3个月非接触式泪膜首次破裂时间和眼表疾病指数问卷一过性下降,6个月恢复。
  • 睑板腺功能评分术后6个月较术前升高。
  • 角膜染色评分与滤过泡血管化及5-氟尿嘧啶注射次数正相关。

核心结论

  • 原发性闭角型青光眼患者行超声乳化联合小梁切除术后可获得较大视力改善和较高手术成功率。
  • 术后3个月客观眼表指标非接触式泪膜首次破裂时间和主观眼表疾病指数问卷出现一过性下降,术后6个月恢复。
  • 睑板腺功能随术后时间推移有一定下降。
  • 角膜染色与术后滤过泡血管化及5-氟尿嘧啶注射次数正相关。

研究设计与样本

  • 回顾性病例系列研究,纳入2021年10月至2023年3月接受超声乳化白内障吸除人工晶状体植入术联合小梁切除术的原发性闭角型青光眼患者51例(51只眼)。
  • 记录术前及术后3个月和6个月最佳矫正视力、眼压、手术并发症、5-氟尿嘧啶结膜下注射情况及多项眼表功能指标。
  • 术后6个月根据Indiana分级方法进行滤过泡分级,探究滤过泡形态与眼表功能的相关性。

主要发现

  • 术前、术后3个月及6个月最佳矫正视力分别为0.22(0.1,0.52)、0.15(0.05,0.4)、0.15(0.1,0.22),术后6个月较术前改善(P=0.004)。
  • 术前、术后3个月及6个月眼压分别为26.9(18.6,33.2)、12.8(11.0,16.3)、12.9(11.2,14.5)mmHg,术后3个月及6个月较术前下降(P<0.001)。
  • 术前、术后3个月及6个月非接触式泪膜首次破裂时间分别为7.46(4.40,11.47)、5.22(3.50,8.15)、7.84(5.93,11.24)s,术后3个月较术后6个月降低(P=0.004)。
  • 术前、术后3个月及6个月眼表疾病指数问卷评分分别为30.56(25.00,38.89)、23.47(17.56,32.88)、25.00(17.62,30.56)分,术后3个月较术前降低(P=0.016)。
  • 术前、术后3个月及6个月睑板腺功能评分分别为3(2,3)、3(2,4)、3(3,4)分,术后6个月较术前升高(P=0.003)。

关键数值与推荐

  • 术后3个月、6个月手术完全成功率分别为98.0%、96.1%,手术条件成功率均为100%。
  • 术前及术后3个月、6个月泪膜平均破裂时间、泪河高度、泪膜动态散射指数、基础泪液分泌试验结果、角膜染色评分差异均无统计学意义(均P>0.05)。
  • 术后6个月,滤过泡血管化及5-氟尿嘧啶注射次数与角膜染色评分呈正相关(r=0.405,P=0.003;r=0.401,P=0.003)。
  • 术后6个月,滤过泡各分级及5-氟尿嘧啶注射次数与术后视力、眼压、其他眼表指数及眼表疾病指数问卷评分均无相关性(均P>0.05)。

临床怎么用

  • 术后3个月应关注患者泪膜稳定性和主观眼表症状的一过性下降,6个月时多可恢复。
  • 术后随访中需监测睑板腺功能,其随术后时间推移有一定下降。
  • 滤过泡血管化明显或5-氟尿嘧啶注射次数较多的患者,应关注角膜染色情况。

局限性

  • 本研究为回顾性病例系列研究,样本量为51例(51只眼)。
  • 随访时间为(7.5±2.1)个月,未报告更长期的眼表变化数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the ocular surface changes and their correlation with filtering bleb morphology after phacoemulsification cataract extraction with intraocular lens implantation (PEI) combined with trabeculectomy for primary angle-closure glaucoma (PACG). Methods: A retrospective case-series study. PACG patients who underwent PEI combined with trabeculectomy between October 2021 and March 2023 were included. Preoperatively and at 3 and 6 months postoperatively, best corrected visual acuity (BCVA), intraocular pressure (IOP), surgical complications, 5-fluorouracil subconjunctival injection, and ocular surface data, including the noninvasive first tear film breakup time (NIF-BUT) and average tear film breakup time, tear meniscus height, tear film dynamic scattering index, Schirmer Ⅰ test, corneal staining score, meibomian gland function score, and ocular surface disease index questionnaire (OSDI), were recorded. At 6 months postoperatively, filtering blebs were graded according to the Indiana Bleb Appearance Grading Scale to explore the correlation between bleb morphology and ocular surface function. Results: A total of 51 patients (51 eyes) were included, comprising 18 males (35.3%) and 33 females (64.7%), with 22 left eyes (43.1%) and 29 right eyes (56.9%). The mean age was 63.9±7.6 years, and the mean follow-up duration was 7.5±2.1 months. The BCVA values at baseline, 3 months, and 6 months postoperatively were 0.22 (0.1, 0.52), 0.15 (0.05, 0.4), and 0.15 (0.1, 0.22), respectively. At 6 months, the BCVA was significantly improved compared with baseline (P=0.004). The IOP at baseline, 3 months, and 6 months was 26.9 (18.6, 33.2) mmHg(1 mmHg=0.133kPa), 12.8 (11.0, 16.3) mmHg, and 12.9 (11.2, 14.5) mmHg, respectively, and was significantly lower at both 3 and 6 months than that at baseline (P<0.001). The complete success rates at 3 and 6 months were 98.0% and 96.1%, respectively, and the qualified success rates were both 100%. No statistically significant differences were found in the noninvasive average tear film breakup time, tear meniscus height, tear film dynamic scattering index, Schirmer Ⅰ test, or corneal staining score among preoperative and postoperative 3-month and 6-month data. The NIF-BUT values at baseline, 3 months, and 6 months were 7.46 (4.40, 11.47) s, 5.22 (3.50, 8.15) s, and 7.84 (5.93, 11.24) s, respectively; the NIF-BUT at 3 months was significantly lower than that at 6 months (P=0.004). The OSDI scores at baseline, 3 months, and 6 months were 30.56 (25.00, 38.89), 23.47 (17.56, 32.88), and 25.00 (17.62, 30.56), respectively; the score at 3 months was significantly lower than that at baseline (P=0.016). The meibomian gland scores at baseline, 3 months, and 6 months were 3 (2, 3), 3 (2, 4), and 3 (3, 4), respectively; the score at 6 months was significantly higher than that at baseline (P=0.003). At 6 months postoperatively, except for the positive correlations of the corneal staining score with bleb vascularity and the number of 5-fluorouracil injections (r=0.405, P=0.003; r=0.401, P=0.003), no significant correlations were found between the bleb grading or number of 5-fluorouracil injections and the postoperative visual acuity, IOP, other ocular surface parameters, or OSDI scores. Conclusions: The PACG patients can achieve good visual improvement and high surgical success rates after PEI with trabeculectomy. A transient decline in the objective ocular surface parameter NIF-BUT and the subjective OSDI score can be observed at 3 months postoperatively, with recovery by 6 months. The meibomian gland function gradually deteriorates over time. The corneal staining can be positively correlated with the postoperative bleb vascularity and the number of 5-fluorouracil injections. 目的: 探讨超声乳化白内障吸除人工晶状体植入术(PEI)联合小梁切除术治疗原发性闭角型青光眼(PACG)后眼表状态变化及与滤过泡形态的相关性。 方法: 本研究为回顾性病例系列研究。收集2021年10月至2023年3月在山东第一医科大学附属青岛眼科医院接受PEI联合小梁切除术治疗的PACG患者51例(51只眼)。记录患者术前及术后3个月和6个月的最佳矫正视力(BCVA,用最小分辨角的对数表示)、眼压、手术并发症、5-氟尿嘧啶结膜下注射情况等基本资料,并记录客观眼表功能检查结果:非接触式泪膜首次破裂时间(NIF-BUT)、泪膜平均破裂时间(NIAvg-BUT)、泪河高度、泪膜动态散射指数(TF-OSI)、基础泪液分泌试验(SⅠt)结果、角膜染色评分、睑板腺功能评分。结合眼表疾病指数(OSDI)问卷进行分析。术后6个月根据Indiana分级方法进行滤过泡分级,探究滤过泡形态与眼表功能的相关性。采用单因素重复测量方差分析、Friedman M检验、Bonferroni校正的Wilcoxon符号秩检验等方法进行统计分析。 结果: 51例(51只眼)患者中,男性18例(35.3%),女性33例(64.7%);年龄为(63.9±7.6)岁,随访时间为(7.5±2.1)个月。患者术前、术后3个月及6个月BCVA分别为0.22(0.1,0.52)、0.15(0.05,0.4)、0.15(0.1,0.22),术后6个月BCVA较术前改善(P=0.004);术前、术后3个月及6个月眼压分别为26.9(18.6,33.2)、12.8(11.0,16.3)、12.9(11.2,14.5)mmHg(1 mmHg=0.133 kPa),术后3个月及6个月眼压较术前下降(P<0.001)。术后3个月、6个月手术完全成功率分别为98.0%、96.1%,手术条件成功率均为100%。患者术前及术后3个月、6个月NIAvg-BUT、泪河高度、TF-OSI、SⅠt结果、角膜染色评分差异均无统计学意义(均P>0.05)。术前、术后3个月及6个月NIF-BUT分别为7.46(4.40,11.47)、5.22(3.50,8.15)、7.84(5.93,11.24)s,术后3个月较术后6个月降低(P=0.004)。术后3个月及6个月OSDI评分分别为30.56(25.00,38.89)、23.47(17.56,32.88)、25.00(17.62,30.56)分,术后3个月较术前降低(P=0.016)。术前、术后3个月及6个月睑板腺功能评分分别为3(2,3)、3(2,4)、3(3,4)分,术后6个月较术前升高(P=0.003)。术后6个月,除滤过泡血管化及5-氟尿嘧啶注射次数与角膜染色评分呈正相关外(r=0.405,P=0.003;r=0.401,P=0.003),滤过泡各分级及5-氟尿嘧啶注射次数与术后视力、眼压、其他眼表指数及OSDI评分均无相关性(均P>0.05)。 结论: PACG患者PEI联合小梁切除术后可获得较大视力改善和较高的手术成功率,术后3个月客观眼表功能指标NIF-BUT和主观功能评分OSDI出现一过性下降并在术后6个月恢复。睑板腺功能随术后时间推移有一定下降,角膜染色与术后滤过泡血管化及5-氟尿嘧啶注射次数正相关。.

来源:Zhonghua Yan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang XY, Wang WN, Gao N, et al. [Correlation of ocular surface changes with filtering bleb morphology after antiglaucoma surgery for primary angle-closure glaucoma]. Zhonghua Yan Ke Za Zhi. 2026. PMID: 42379866. doi:10.3760/cma.j.cn112142-20250801-00326

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。